Radiotherapy, a standard of care treatment for localized prostate cancer includes, has shown remarkable success. This ...

Christmas was approaching so Rick Hollering, executive director of the Youth Services Alliance, brought a gift to his class at The Academy. Hollering had been visiting The Academy, a school within the ...

Vistagen has reported positive outcomes from the exploratory Phase IIA trial of an investigational pherine nasal spray, PH284, for the treatment of cancer cachexia. The 'previously unreported ...

On January 14, 2025, Soligenix, Inc. (NASDAQ:SNGX) announced additional positive data from the open ... with HyBryte is leading to improved outcomes for patients. We anticipate additional updates ...